Navigation Links
Novelos Therapeutics Announces Enrollment of First Patient in Solid Tumor Imaging Trial with I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center
Date:10/25/2012

MADISON, Wis., Oct. 25, 2012 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center (UWCCC), a leading oncology research institution, has enrolled the first patient in a Phase 1-2 positron emission tomography (PET) imaging trial of I-124-CLR1404 (LIGHT), a cancer-targeted PET imaging agent, in patients with nine solid tumor types, including triple negative breast, soft tissue sarcoma, colorectal, gastric, esophageal, prostate, ovarian, pancreatic and head & neck cancer.  Details of the trial design are available at www.clinicaltrials.gov ID: NCT01662284, or at www.novelos.com in the 'Clinical Trials' section.  Glenn Liu, M.D., Associate Professor of Medicine and Director of the Cancer Therapy Discovery and Development (Phase I) Program at the UWCCC, is the trial's principal investigator.

"We are pleased to begin enrollment in this trial to evaluate LIGHT across multiple solid tumor types," said Dr. Liu.  "Oncologists are in need of better tools to diagnose patients more accurately and LIGHT has the potential to improve upon currently used standard approaches.  Accurate diagnosis of local, regional and distant metastatic spread is critical for optimal management and improved accuracy of staging may also spare patients the morbidity of unnecessary, non-curative surgical procedures."

"We are very pleased to be expanding our collaboration with the UW Carbone Cancer Center," said Harry Palmin, President and CEO of Novelos.  "Having demonstrated initial positive LIGHT imaging data in lung and brain cancer patients this year, we now look forward to obtaining initial LIGHT imaging data across nine other solid tumor indications starting in the first quarter of 2013.  We believ
'/>"/>

SOURCE Novelos Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
2. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
3. Novelos Therapeutics Prices $5.4 Million Public Offering
4. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
5. Novelos Therapeutics to Present at Rodman & Renshaw 14th Annual Healthcare Conference on September 11
6. Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress
7. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
8. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
9. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
10. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
11. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 The steady decline ... spreading to previously rep-friendly specialties, according to the ... marketing consulting firm ZS Associates.      ... U.S. pharmaceutical sales teams. The report examines how ... with the pharmaceutical sales reps who visit their ...
(Date:7/22/2014)... -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: ... appointed Charles J. (Chuck) Bramlage and Dr. ... Board.  Mr. Bramlage is a veteran ... and other commercial functions.  He is currently the Chief ... company that was recently acquired by AstraZeneca and is ...
(Date:7/22/2014)... , July 22, 2014  UL (Underwriters ... that the U.S. Food and Drug Administration (FDA) ... consensus standards for medical devices incorporating lithium or ... - Standard for Household and Commercial Batteries, and ... Consensus standards are standards recognized ...
Breaking Medicine Technology:Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 2BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 3BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 4BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 5BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 6BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 7Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices 2
... China Medicine Corporation (OTC Bulletin Board: CHME ... of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other ... announced that it has filed with the United States ... Form 8-K to disclose that its previously issued financial ...
... THOUSAND OAKS, Calif., March 23, 2011 Amgen ... data that showed postmenopausal women with osteoporosis had ... (denosumab) treatment than during alendronate treatment, an oral ... Adherence to treatment, which includes both compliance ...
Cached Medicine Technology:China Medicine Corporation Files Extension for Fiscal 2010 Form 10-K Filing 2China Medicine Corporation Files Extension for Fiscal 2010 Form 10-K Filing 3Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 2Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 3Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 4Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 5Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 6Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 7Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 8Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 9Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 10Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate 11
(Date:7/22/2014)... (PRWEB) July 22, 2014 An Ideal ... is located in the naturally tranquil and very beautiful ... Its location is ideal for both a rehabilitative setting, ... traditional Independence Day display of fireworks. Launched over ... the beach, while swimming in the lake, or from ...
(Date:7/22/2014)... FL (PRWEB) July 22, 2014 Joining Conquer ... cure paralysis in the next decade is Paralympic silver medalist ... snowboarding accident, French became a quadriplegic from a spinal cord ... to help find a cure for paralysis. , “People define ... for others, it’s something else. We have the image in ...
(Date:7/22/2014)... Reston, VA (PRWEB) July 22, 2014 ... providing integrated visibility and automated recovery at the ... the shift from infrastructure-focused to application-centric management. ... ten senior IT executives, the report provides insights, ... IT executives related to application and system uptime. ...
(Date:7/22/2014)... July 22, 2014 The demand for revision ... surgeons whose waiting rooms are filled with patients who seek ... of people electing to have plastic surgery continues to rise ... do cosmetic procedures is increasing, it is not surprising that ... growing. , According to New York City Facial Plastic Surgeon ...
(Date:7/22/2014)... NewfoundLand (PRWEB) July 22, 2014 2014 ... Award is thrilled to announce the 2014 Top Service ... would like to extend heartfelt congratulations to all this ... with the people of St. John’s. , Each year ... expectations through the responses of thousands of consumers and ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Holds Annual Firework Event 2Health News:Narconon Arrowhead Holds Annual Firework Event 3Health News:Paralympian Jen French Announced as Conquer Paralysis Now’s First Champion 2Health News:JumpSoft Releases Report on Shift from Infrastructure-Centric to Application-Centric IT Management 2Health News:JumpSoft Releases Report on Shift from Infrastructure-Centric to Application-Centric IT Management 3Health News:Cosmetic Surgery Regret Is On The Rise 2Health News:Cosmetic Surgery Regret Is On The Rise 3Health News:2014 St. John's Consumer Choice Award Winners 2Health News:2014 St. John's Consumer Choice Award Winners 3Health News:2014 St. John's Consumer Choice Award Winners 4
... Germany, September 22 The,Gerresheimer Group expands its ... significant investments in the USA and,Europe. This week ... research,and development center for medical plastic systems in ... for pharmaceutical plastic packaging in Spain.,"Plastics are increasingly ...
... ... Two years ago, Barbara Ladd McNamara suffered a ruptured brain aneurysm. She ... Brain Aneurysm Center at St. Joseph,s Hospital, where physicians Eric Nussbaum and ... remarkable 12 more aneurysms to address. Over the course of several months, ...
... The answer to the health care crisis ... because there is a way to cut health care costs by 20%. , ... Los Angeles, CA (PRWEB) September 22, 2009 -- The answer to the health ... is unnecessary because there is a way to cut health care costs by 20%., , ...
... Report presents findings by wage level and gender and ... , NEW YORK, Sept. 22 In the midst of ... a time of heightened economic insecurity, new data on employers show that ... of important areas. The State of Health in the American Workforce ...
... , SCOTTSDALE, Ariz., Sept. 21 ... non-traded real estate investment trust, announced the completed acquisition of ... Greenville, South Carolina for approximately $162,820,000 on September 18, 2009. ... provider of healthcare services in South Carolina with approximately 70% ...
... Los Angeles, London, New Delhi, Singapore and Washington DC (September ... series of papers published today assess the effects of the ... and the Pacific. Crisis for Children, a special issue of ... be made that will not only advance children,s rights and ...
Cached Medicine News:Health News:Gerresheimer Expands in the Global Pharmaceutical Plastic Business 2Health News:Gerresheimer Expands in the Global Pharmaceutical Plastic Business 3Health News:Brain Aneurysm Patients Have A New Voice With Brain Storms Blog 2Health News:Brain Aneurysm Patients Have A New Voice With Brain Storms Blog 3Health News:Powerful Key to Cutting Healthcare Costs Revealed in "The Self Image Solution" 2Health News:New Families and Work Institute Study Reveals Declines in the Health of American Workforce 2Health News:New Families and Work Institute Study Reveals Declines in the Health of American Workforce 3Health News:New Families and Work Institute Study Reveals Declines in the Health of American Workforce 4Health News:New Families and Work Institute Study Reveals Declines in the Health of American Workforce 5Health News:Healthcare Trust of America, Inc. Completes Acquisition of 856,000 SF Greenville Hospital System Medical Office Building Portfolio 2Health News:Healthcare Trust of America, Inc. Completes Acquisition of 856,000 SF Greenville Hospital System Medical Office Building Portfolio 3Health News:999: The human face of economic crisis 2Health News:999: The human face of economic crisis 3
... Vitrectomy Lenses are a family of single-use direct ... of a particular region of the retinal surface ... less than 1 gram and is formed and ... of a human cornea. Lenses come in boxes ...
... The AFX Lens is a ... use in an air-filled eye. ... as a primary air-fluid exchange ... and sutureless design make it ...
... The Chalam 30° Prism are ... and are recommended for tractional ... and Rhegmatogenus retinal detachment. They ... photocoagulation and other midperipheral laser ...
... 45° Prism is designed ... and are recommended for ... BRVO etc.) and Rhegmatogenus ... be used for panretinal ...
Medicine Products: